Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Compass Therapeutics
Exelixis
Mayo Clinic
Mayo Clinic
Ohio State University
Hoffmann-La Roche
Xencor, Inc.
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Pfizer
Duke University
National Institutes of Health Clinical Center (CC)
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Novartis
Genentech, Inc.
A2 Biotherapeutics Inc.
OHSU Knight Cancer Institute
University of Oklahoma
Poseida Therapeutics, Inc.
St. Jude Children's Research Hospital
MacroGenics
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Novartis
SAPU NANO (US) LLC
National Institutes of Health Clinical Center (CC)
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Novartis
Kura Oncology, Inc.
Elephas
City of Hope Medical Center
Mayo Clinic
GlaxoSmithKline
Sairopa B.V.
Incyte Corporation
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Mayo Clinic
Gustave Roussy, Cancer Campus, Grand Paris
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.